share_log

Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4

Maxim Group Initiates Coverage On Blue Water Vaccines With Buy Rating, Announces Price Target of $4

Maxim集团以买入评级开始对蓝水疫苗进行报道,宣布目标价为4美元
Benzinga Real-time News ·  2022/12/08 08:42

Maxim Group analyst Jason McCarthy initiates coverage on Blue Water Vaccines (NASDAQ:BWV) with a Buy rating and announces Price Target of $4.

Maxim Group分析师Jason McCarthy以买入评级启动蓝水疫苗(纳斯达克:BWV)的报道,并宣布目标价为4美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发